Cephalexin
54 NDCs across 8 manufacturers|54 Generic,0 Brand
Cephalexin is used to treat human bites, infectious bone diseases, escherichia coli infections, haemophilus infections, klebsiella infections and moraxellaceae infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 32 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $58 million on Cephalexin across 7.5 million claims for 5.3 million beneficiaries.
Cephalexin is available as 54 NDCs from 8 manufacturers (54 generic, 0 brand), with NADAC prices from $0.09 to $5.11 per EA — the most expensive product costs about 56× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
54
54G / 0B
Manufacturers
8
competing in market
Price Spread
$0.09 – $5.11
per EA, 38 of 54 NDCs
7d Activity
avg -1.8% WoW · of 54 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Ascend Laboratories, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Cephalosporin Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing CEPHALEXIN
Frequently Asked Questions
What is Cephalexin used to treat?
Cephalexin is used to treat human bites, infectious bone diseases, escherichia coli infections, haemophilus infections, klebsiella infections and moraxellaceae infections, per the National Library of Medicine's MED-RT classification.
When did Cephalexin become available as a generic?
FDA approved the first generic Cephalexin (ANDA) on Jan 1, 1982. The Orange Book currently lists 32 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cephalexin?
In 2024, Medicare Part D spent $58 million on Cephalexin across 7.5 million claims for 5.3 million beneficiaries.
How many Cephalexin products are on the market?
The Cephalexin drug market contains 54 NDCs from 8 manufacturers — 54 generic and 0 brand products.
What is the price range for Cephalexin?
NADAC reference prices for Cephalexin range from $0.0905 to $5.1116 per EA — the most expensive product costs about 56× the cheapest. 16 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Cephalexin?
8 manufacturers list Cephalexin in NADAC. Ranked by number of NDCs, the largest are Ascend Laboratories, LLC (13), Aurobindo Pharma Limited (10), Teva Pharmaceuticals USA Inc. (10), Lupin Pharmaceuticals Inc. (8), Chartwell RX LLC (6).
How has the price of Cephalexin changed recently?
Over the past 7 days, 8 Cephalexin NDCs rose and 45 fell, with a market-wide average change of -1.8%.